Nektar Therapeutics
NKTR
#5687
Rank
NZ$2.00 B
Marketcap
NZ$98.49
Share price
-1.37%
Change (1 day)
275.87%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -NZ$0.2 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are NZ$62.6 Million. In 2024 the company made an earning of -NZ$0.21 Billion, an increase over its 2023 earnings that were of -NZ$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.2 Billion-5.76%
2024 -NZ$0.21 Billion-56.85%
2023 -NZ$0.48 Billion-24.31%
2022 -NZ$0.64 Billion-30.25%
2021 -NZ$0.91 Billion17.87%
2020 -NZ$0.77 Billion0.88%
2019 -NZ$0.77 Billion-164.46%
2018 NZ$1.18 B-810.61%
2017 -NZ$0.17 Billion-37.06%
2016 -NZ$0.27 Billion89.22%
2015 -NZ$0.14 Billion48.22%
2014 -NZ$94.22 Million-65.93%
2013 -NZ$0.28 Billion-6.81%
2012 -NZ$0.3 Billion28.95%
2011 -NZ$0.24 Billion258.8%
2010 -NZ$64.15 Million-63.94%
2009 -NZ$0.18 Billion-392.45%
2008 NZ$60.83 M-211.74%
2007 -NZ$54.45 Million-79.57%
2006 -NZ$0.27 Billion-16.9%
2005 -NZ$0.33 Billion81.53%
2004 -NZ$0.18 Billion54.19%
2003 -NZ$0.12 Billion-33.87%
2002 -NZ$0.18 Billion-9.6%
2001 -NZ$0.2 Billion73.39%
2000 -NZ$0.12 Billion108.9%
1999 -NZ$52.91 Million39.48%
1998 -NZ$37.94 Million60.02%
1997 -NZ$23.71 Million18.05%
1996 -NZ$20.08 Million31.82%
1995 -NZ$15.24 Million57.14%
1994 -NZ$9.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$14.27 B-7,345.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.51 B-10,516.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.96 B-20,393.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
NZ$0.26 M-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.65 B-11,604.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-NZ$0.47 Billion 137.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$0.70 B-456.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
NZ$56.07 B-28,571.74%๐Ÿ‡บ๐Ÿ‡ธ USA